| Fludeoxyglucose (F-18) | 🇨🇦Canada | 232 GBQ / VIAL | Solution | Marketed | Lawson Health Research Institute |
| 18F-Fludeoxyglucose (18F-FDG) | 🇨🇦Canada | 7400 MBq / ML | Solution | Marketed | Isologic Innovative Radiopharmaceuticals LTD. |
| [F-18]-Fludeoxyglucose (FDG) Injection | 🇨🇦Canada | 441 GBQ / VIAL | Solution | Marketed | Sylvia Fedoruk Canadian Centre for Nuclear Innovation |
| Fludeoxyglucose [F-18] FDG Injection | 🇨🇦Canada | 0.5 GBQ / VIAL | Solution | Marketed | Thunder Bay Regional Health Sciences Centre |
| Fludeoxyglucose (18F) Injection | 🇨🇦Canada | 0.5 GBQ / 16 ML | Solution | Marketed | Shared Health |
| Fludeoxyglucose (18F) Injection | 🇨🇦Canada | 0.5 GBQ / VIAL | Solution | Marketed | BC Cancer, Part of the Provincial Health Services Authority |
| Fludeoxyglucose [F-18] FDG Injection | 🇨🇦Canada | 0.5 GBQ / VIAL | Solution | Authorised | Thunder Bay Regional Health Sciences Centre |
| Fluglucoscan | 🇨🇦Canada | 0.5 GBQ / VIAL | Solution | Marketed | Alberta Health Services |
| Atlantiscan | 🇨🇦Canada | 200 MCI / ML | Solution | Marketed | Nova Scotia Health Authority |
| Cyclodx | 🇨🇦Canada | 7.4 GBQ / ML | Solution | Marketed | Ciuss de L'Estrie - Centre Hospitalier Universitaire de Sherbrooke |
| Fludeoxyglucose F18 Injection | 🇨🇦Canada | 7.4 MBq / ML | Solution | Cancelled | Montreal Neurological Institute |
| Fluorohmet (Citrate) | 🇨🇦Canada | 157 GBQ / VIAL | Solution | Not marketed | University of Ottawa Heart Institute - National Cardiac Pet Centre |
| Fluorohmet (Phosphate) | 🇨🇦Canada | 157 GBQ / VIAL | Solution | Not marketed | University of Ottawa Heart Institute - National Cardiac Pet Centre |
| Gludef | 🇨🇦Canada | 51.5 GBQ / 5 ML | Solution | Cancelled | Isologic Innovative Radiopharmaceuticals LTD. |
| Gludef | 🇨🇦Canada | 232 GBQ / 20 ML | Solution | Cancelled | Isologic Innovative Radiopharmaceuticals LTD. |
| Glucovision (Citrate) | 🇨🇦Canada | 453 GBQ / SYR | Solution | Cancelled | Centre for Probe Development and Commercialization |
| Glucovision (Citrate) | 🇨🇦Canada | 453 GBQ / VIAL | Solution | Cancelled | Centre for Probe Development and Commercialization |
| Glucovision (Phosphate) | 🇨🇦Canada | 540 GBQ / VIAL | Solution | Cancelled | Centre for Probe Development and Commercialization |
| Glucovision (Phosphate) | 🇨🇦Canada | 540 GBQ / SYR | Solution | Cancelled | Centre for Probe Development and Commercialization |
| Cantrace | 🇨🇦Canada | 732 MBq / ML | Solution | Cancelled | Ipet Pharmaceuticals INC. |
